← Insider buys
NTLA

Intellia Therapeutics, Inc. · Healthcare

President and CEO John M Leonard sold $12.0M of Intellia Therapeutics, Inc.

Sold$11,955,395
$67.26Price
177,745Shares
−21%Stake

What NTLA did after the filing

Prices for NTLA after this filing aren't in yet.

Traded Mon, Feb 1. Filed Wed, Feb 3, 9:39 PM ET, after the close. Not investment advice.